Pacer Advisors’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.46M Sell
743,904
-65,020
-8% -$153K ﹤0.01% 1071
2025
Q4
$2.19M Sell
808,924
-62,596
-7% -$205K 0.01% 1033
2025
Q3
$3.69M Buy
+871,520
New +$3.83M 0.01% 804

Other funds holding GDRX

Pacer Advisors's GDRX Position: Q1 2026 in Review

Pacer Advisors reduced its GoodRx Holdings (GDRX) stake by 8% in Q1 2026, selling an estimated $153K and leaving 743,904 shares worth $1.46M. The position accounts for ﹤0.01% of the portfolio, ranked #1071.

Pacer Advisors first reported a position in GDRX in Q3 2025 and has held it in 3 quarters since. The position peaked at $3.69M in Q3 2025. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Pacer Advisors held 743,904 shares of GoodRx Holdings worth $1.46M as of Q1 2026.
  • Pacer Advisors sold 65,020 GoodRx Holdings shares in Q1 2026, an estimated $153K.
  • GoodRx Holdings made up ﹤0.01% of Pacer Advisors's portfolio in Q1 2026, its #1071 holding.
  • Pacer Advisors first reported a position in GoodRx Holdings in Q3 2025 and has held it in 3 quarters since.
  • Pacer Advisors's GoodRx Holdings position peaked at $3.69M in Q3 2025.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Pacer Advisors's 13F filing for Q1 2026, filed 6 May 2026.